

Coca-Cola Europacific Partners vs Kimberly-Clark
Major Coca-Cola bottler across Europe and Asia-Pacific vs Global maker of tissue and personal care products. Which is the better buy for your portfolio in July 2026? Plain-English answer below.
Coca-Cola Europacific Partners bottles and distributes Coke products across Western Europe and Australia under a long-term franchise agreement with the Coca-Cola Company, while Kimberly-Clark sells Kleenex, Huggies, and Scott paper products to households around the world. Coca-Cola Europacific Partners vs Kimberly-Clark both generate predictable cash flows from consumer staples brands with deep shelf-space dominance, making them favorites for dividend investors. The analysis examines organic revenue growth, volume trends, cost pass-through ability, and which company delivers stronger earnings per share growth.
Coca-Cola Europacific Partners bottles and distributes Coke products across Western Europe and Australia under a long-term franchise agreement with the Coca-Cola Company, while Kimberly-Clark sells Kl...
Why It’s Moving

CCEP is under pressure as analysts flag stretched valuation and limited cushion below the stock.
- Analysts turned more cautious on valuation, saying CCEP is trading at a premium to its historical range and the broader beverage sector, which is keeping downside risk front and center.
- Recent technical readouts point to weak support and an unfavorable risk-reward setup, suggesting the stock may be more exposed if sentiment sours.
- Broader ownership and insider-trading chatter has added to the cautious tone, with investors watching for any sign that big holders or executives are losing conviction.

KMB’s upside case hinges on whether cost cuts can outweigh softer sales and margin pressure.
- Analysts are still pointing to mixed momentum: softer North America sales and cost pressure are weighing on the near-term setup, even as investors watch for benefits from ongoing portfolio cleanup and efficiency efforts.
- The stock is being framed around a broader improvement story, with analysts focusing on whether divestitures and cost synergies can offset weak category trends and input-cost uncertainty.
- Recent analyst views remain mostly cautious, which makes any upside case depend less on a single catalyst and more on evidence that margin discipline and business transformation are starting to show through.

CCEP is under pressure as analysts flag stretched valuation and limited cushion below the stock.
- Analysts turned more cautious on valuation, saying CCEP is trading at a premium to its historical range and the broader beverage sector, which is keeping downside risk front and center.
- Recent technical readouts point to weak support and an unfavorable risk-reward setup, suggesting the stock may be more exposed if sentiment sours.
- Broader ownership and insider-trading chatter has added to the cautious tone, with investors watching for any sign that big holders or executives are losing conviction.

KMB’s upside case hinges on whether cost cuts can outweigh softer sales and margin pressure.
- Analysts are still pointing to mixed momentum: softer North America sales and cost pressure are weighing on the near-term setup, even as investors watch for benefits from ongoing portfolio cleanup and efficiency efforts.
- The stock is being framed around a broader improvement story, with analysts focusing on whether divestitures and cost synergies can offset weak category trends and input-cost uncertainty.
- Recent analyst views remain mostly cautious, which makes any upside case depend less on a single catalyst and more on evidence that margin discipline and business transformation are starting to show through.
Investment Analysis
Pros
- Reported solid Q3 2025 revenue growth of 1.0%, driven by volume growth and higher revenue per unit case.
- Continues to increase market share ahead of competition within its territories.
- Receives mostly positive analyst sentiment, with an average price target indicating upside potential near 9-19%.
Considerations
- Modest volume growth at only 0.4% in Q3 suggests limited near-term expansion in core beverage sales.
- Analyst opinions are mixed, with some Hold and Sell ratings alongside Buy recommendations, reflecting some uncertainty.
- Short selling activity remains notable at 8.88%, indicating some investor bearishness or hedging.
Pros
- Kimberly-Clark's price-to-earnings ratio of 16.27 is below its 3-, 5-, and 10-year averages, potentially indicating value relative to its history.
- Market capitalization around $31 billion reflects its status as a leading global consumer goods company.
- Maintains steady financial metrics amid competitive pressure in personal care and household products.
Considerations
- Current PE ratio below historical averages may partly reflect slower growth or margin pressure concerns.
- Faces industry-wide challenges including inflationary cost pressures and evolving consumer preferences.
- Competitive dynamics could impact pricing power and margin sustainability in key product categories.
Coca-Cola Europacific Partners (CCEP) Next Earnings Date
CCEP’s next earnings date is currently expected around August 5–12, 2026, with some calendars pointing to August 12, 2026 as the most likely release date. The company has not officially announced the date yet. The report should cover Q2 2026 earnings.
Kimberly-Clark (KMB) Next Earnings Date
Kimberly-Clark’s next earnings release is typically expected in late July to early August 2026, with current estimates clustering around July 28, 2026 to August 7, 2026. The report will cover Q2 2026 results, based on the company’s quarterly reporting cycle following its Q1 2026 release in late April. If the company has not formally confirmed a date, the most defensible expectation is an announcement in the final week of July or first week of August.
Coca-Cola Europacific Partners (CCEP) Next Earnings Date
CCEP’s next earnings date is currently expected around August 5–12, 2026, with some calendars pointing to August 12, 2026 as the most likely release date. The company has not officially announced the date yet. The report should cover Q2 2026 earnings.
Kimberly-Clark (KMB) Next Earnings Date
Kimberly-Clark’s next earnings release is typically expected in late July to early August 2026, with current estimates clustering around July 28, 2026 to August 7, 2026. The report will cover Q2 2026 results, based on the company’s quarterly reporting cycle following its Q1 2026 release in late April. If the company has not formally confirmed a date, the most defensible expectation is an announcement in the final week of July or first week of August.
Buy CCEP or KMB in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


